Know your third party patent rights

In the competitive world of the biosciences, third party patent rights (TPRs) can stand in the way of a planned course of action, even after significant investment has been made. Knowledge of such rights...

The IP journey and risk mitigation

Paul Storer Senior Policy Adviser in the Business Support Policy Team at the IPO Resolving IP disputes can be costly and the Intellectual Property Office continues to seek to reduce costs for businesses, not only in...

The search for new antimicrobials

Few issues are more pressing than the global problem of antibiotic resistance, so we speak to Professor Mathew Upton, about his work searching for new antibiotics. “For so long now, antibiotics have been seen as...

New research predicts a positive future for biosimilars

The prospect of reducing treatment costs for payors supports a positive future for biosimilars Biosimilar approvals in the US market still significantly lag behind Europe despite an evolving regulatory landscape and three new...

A new way to manufacture small batches of biopharmaceuticals on demand

Biopharmaceuticals, a class of drugs comprising proteins such as antibodies and hormones, represent a fast-growing sector of the pharmaceutical industry. They’re increasingly important for “precision medicine” — drugs tailored toward the genetic or molecular...

Making Pharmaceuticals person-specific

Dr Mohammed Maniruzzaman: Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex In this issue of BioScience Today, we speak to Dr Mohammed Maniruzzaman, Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex,...

UK-led study marks shift towards genetic era in tackling TB

In a landmark study that may herald a quicker, more tailored treatment for the millions of people around the world living with tuberculosis (TB), UK researchers have shown how our understanding of TB’s genetic...

New ‘trap’ to analyse, in real time, how cells communicate

Using multiple laser beams and Raman spectroscopy, experts at the Universities of Nottingham and Glasgow have designed and built a new instrument which could help scientists learn more about how infections take hold and...

Researchers discover how fatal biofilms form

By severely curtailing the effects of antibiotics, the formation of organized communities of bacterial cells known as biofilms can be deadly during surgeries and in urinary tract infections. Yale researchers have just come a...

Discovery helps fight against drug-resistant Tuberculosis

A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis. Each year, approximately 10 million people fall ill with Tuberculosis (TB) and around 1.7 million die...

Using apprenticeships to build skills for innovation in life sciences

Dr. Gillian Burgess, Site Head of UK Research and Vice President at Vertex Pharmaceuticals and Board Member of the Science Industry Partnership (SIP) of employers, sets out the business case for greater use of apprenticeships across...

Regulator protein key to malaria parasite’s lifecycle

Malaria remains a significant threat to human health with approximately 216 million cases annually and over 400,000 deaths worldwide. It is caused by the Plasmodium parasite, which has a complex lifecycle involving transmission to...

Discovery aids disease elimination efforts

David Horn: Professor of Parasite Molecular Biology, University of Dundee Researchers at the University of Dundee have identified a new drug target in parasites that cause major neglected tropical diseases, a discovery that contributes towards a...

Could your accountant have made a mistake with your Research and Development Tax Relief...

How would you know? What can you do about it? You could start by speaking with a specialist and even better someone who’s worked in a Top 5 CRO preparing claims for 6 years! Now...

Crowdfunding: 21st century capital for startups and SMEs

Although Britain has long been recognised as a country of pioneering scientists, inventors and entrepreneurs, it has historically been poor at making sufficient capital available for this creativity to blossom fully to the UK’s...

Having access to finance is an essential ingredient to grow and prosper

Graeme Fisher: Managing Director for Communications and Policy at British Business Bank Smaller businesses are a fundamental part of the UK economy, driving growth and employment creation. Those businesses categorised as small and medium-sized enterprises (SMEs)...